FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers All Category, Blogs, GMP Compliance, Medical Device, regulatory / development / March 10, 2026 FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers Read More »
Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul All Category, Blogs, Pharmacovigilance / development / March 2, 2026 Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul Read More »
Inspection Findings Related to Vendor Oversight in Pharmacovigilance All Category, Blogs, Pharmacovigilance / Nikita Saraswat / February 27, 2026 Inspection Findings Related to Vendor Oversight in Pharmacovigilance Read More »
Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates All Category, Blogs, Pharmacovigilance / development / February 24, 2026 Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates Read More »
Regulatory Impact of Manufacturing Site Transfers All Category, Blogs, GMP Compliance, regulatory / development / February 20, 2026 Regulatory Impact of Manufacturing Site Transfers Read More »
UDI Requirements Across US, EU, and Other Emerging Markets All Category, Blogs, Medical Device, regulatory / development / February 18, 2026 UDI Requirements Across US, EU, and Other Emerging Markets Read More »
Post-Market Clinical Follow-Up in Medical Devices: Regulatory Obligations and Documentation All Category, Blogs, Medical Device, regulatory / development / February 20, 2026 Post-Market Clinical Follow-Up in Medical Devices: Regulatory Obligations and Documentation Read More »
Signal Detection in Pharmacovigilance: Regulatory Expectations and Tools All Category, Blogs, Pharmacovigilance, regulatory / development / February 11, 2026 Signal Detection in Pharmacovigilance: Regulatory Expectations and Tools Read More »
Ethnic Sensitivity Factors Considered in Global Drug Development All Category, Blogs, Clinical Regulatory, regulatory / development / February 13, 2026 Ethnic Sensitivity Factors Considered in Global Drug Development Read More »
Regulatory Requirements for Post-Authorization Safety Studies (PASS) All Category, Blogs, Pharmacovigilance / development / February 4, 2026 Regulatory Requirements for Post-Authorization Safety Studies (PASS) Read More »
